Get the App
A

Arbutus Biopharma (ABUS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more

  • USD3.01
  • USD3.07
  • USD2.98
  • USD3.22
  • 13.20%
  • 51M
  • 615.57k
  • 1.11M
  • 488M
  • 1.85
  • -0.70%

Stock News

The Moneyist: ‘They do not trust her, nor do I’: My elderly parents fear my sister will empty their bank accounts and steal their possessions. What can we do?

25 minutes ago

The Moneyist: ‘They do not trust her, nor do I’: My elderly parents fear my sister will empty their bank accounts and steal their possessions. What can we do?

MarketWatch

Cohen & Steers Closed-End Funds Declare Distributions for April, May, and June 2023

29 minutes ago

Cohen & Steers Closed-End Funds Declare Distributions for April, May, and June 2023

Yahoo

Living With Climate Change: Wind damage will impact more U.S. homes than before, in Florida especially. How best to protect your property.

29 minutes ago

Living With Climate Change: Wind damage will impact more U.S. homes than before, in Florida especially. How best to protect your property.

MarketWatch

PowerSchool Introduces International Localization Framework to Support Growing Global Customer Base

44 minutes ago

PowerSchool Introduces International Localization Framework to Support Growing Global Customer Base

Yahoo

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium